Cochlear logo

Cochlear(ASX) COH

Market CapA$8.76BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (1995)+8,970%
5 Year-39%
1 Year-54%
1 Month-2%
A$140.95
+6.30%
+8.35Today
Cochlear last closing stock price
MetricPriceDate
Last closeAUD 132.602026-09-18
Cochlear stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week-0.18%AUD 132.842026-09-11
1 month-2.48%AUD 135.972026-08-19
3 month+13.34%AUD 116.992026-06-19
Year to date-47.98%AUD 254.912025-12-31
1 year-54.05%AUD 288.562025-09-18
3 year-46.6%AUD 248.322023-09-19
5 year-39.44%AUD 218.972021-09-17
Since inception+8,969.66%AUD 1.481995-12-12

Cochlear Financials at a Glance

Market Cap

A$8.76BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

A$4.69B

Net Income (TTM)

A$536.20M

EPS (TTM)

A$2.25

P/E Ratio

59.47

Dividend

A$4.30

Beta (Volatility)

-0.11 (Low)

Price

A$140.95

Volume

350,606

Open

A$133.53

Previous Close

A$140.95

Daily Range

A$133.12 - A$140.95

52-Week Range

A$88.74 - A$296.50

Estimated Earnings Date

Feb 16, 2027

COH News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Cochlear

Cochlear Limited specializes in developing and providing implantable auditory solutions for children and adults. Established in 1981 and headquartered in Sydney, Australia, the company offers advanced cochlear implant systems, bone conduction devices, and a variety of accessories.

Products and Services
  • Advanced cochlear implant systems for hearing restoration
  • Bone conduction devices for individuals with conductive hearing loss
  • Upgrades and accessories for enhanced user experience
Growth Outlook
  • Strong demand for hearing solutions drives market expansion
  • Investment in R&D supports innovative product development
  • Global market presence enhances revenue opportunities
Financial Highlights
  • Recent quarterly revenue of AUD 1.16 billion reflects solid performance
  • Trailing twelve months (TTM) net income margin at 6.31% indicates profitability
  • Dividend yield of 3.16% offers attractive returns to shareholders
Cochlear Limited has established itself as a leader in the medical devices industry, particularly in auditory solutions. The company's commitment to innovation and quality has positioned it well for future growth. Recent financial performance demonstrates resilience, with a notable revenue figure in the latest quarter. The focus on research and development is expected to yield new products, further enhancing market share. With a strong dividend yield, Cochlear Limited presents an appealing option for investors interested in the healthcare sector.
AI Generated • Aug 30, 2026

Industry

Healthcare Equipment and Supplies

Employees

5,400

CEO

Diggory William Howitt, MBA

Headquarters

Sydney, NSW 2109, AU

COH Financials

Key Financial Metrics (TTM)

Gross Margin

70.53%

Operating Margin

12.89%

Net Income Margin

6.31%

Return on Equity

8.01%

Return on Capital

15.41%

Return on Assets

5.66%

Earnings Yield

1.68%

Dividend Yield

3.21%

Payout Ratio

1.91%

Stock Overview

Market Cap

A$8.76BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

65.40M

Volume

350.61K

Avg. Volume

604.80K

Financials (TTM)

Gross Profit

A$3.39B

Operating Income

A$826.80M

EBITDA

A$1.02B

Operating Cash Flow

A$605.60M

Capital Expenditure

-A$123.50M

Free Cash Flow

A$482.10M

Cash & ST Invst.

A$187.70M

Total Debt

A$212.70M

Cochlear Performance Analysis

Cochlear annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20232023-06-30AUD 1,955,700,00019.2%
20242024-06-30AUD 2,258,200,00015.5%
20252025-06-30AUD 2,355,800,0004.3%
20262026-06-30AUD 2,334,700,000-0.9%
Cochlear sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22024-12-302.4%
Q42025-06-301.2%
Q22025-12-31-0.8%
Q42026-06-30-1.5%
Cochlear annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20232023-06-30AUD 4.563.8%
20242024-06-30AUD 5.4319.0%
20252025-06-30AUD 5.939.2%
20262026-06-30AUD 2.25-62.1%
Cochlear sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22024-12-3024.2%
Q42025-06-30-10.5%
Q22025-12-31-12.1%
Q42026-06-30-108.9%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2026YOY CHG

Revenue

A$1.16B

+1.2%

Gross Profit

A$789.90M

-9.1%

Gross Margin

68.17%

N/A

Market Cap

A$8.76BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

A$1.62M

N/A

Employees

5,400

N/A

Net Income

-A$14.20M

-108.6%

EBITDA

A$134.60M

-50.5%

Quarterly Fundamentals

Name
Q4 2026YOY CHG

Total Cash

A$187.70M

-63.5%

Total Debt

A$212.70M

-12.7%

Accounts Receivable

A$559.20M

+14.0%

Inventory

A$491.30M

+25.5%

Long Term Debt

A$170.70M

-15.5%

Short Term Debt

A$42.00M

+1.0%

Return on Assets

5.66%

N/A

Return on Invested Capital

15.06%

N/A

Free Cash Flow

A$198.10M

+3.2%

Operating Cash Flow

A$231.20M

-0.2%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
SHL.AXSonic Healthcare Limited
A$19.47+1.20%
PNV.AXPolyNovo Limited
A$0.98+2.63%
IMR.AXImricor Medical Systems, Inc.
A$1.78-3.78%
EBR.AXEBR Systems, Inc.
A$0.27+1.92%

Trending Stocks

Symbol / CompanyPricePrice Chg
IBITiShares Bitcoin Trust
$46.02+6.28%
BITOProShares Trust - ProShares Bitcoin ETF
$10.92+6.23%
INTCIntel
$108.60-0.18%
CONLGraniteShares ETF Trust - GraniteShares 2x Long Coin Daily ETF
$6.27+23.18%

Questions About COH

What is the current price of Cochlear?

Cochlear is trading at A$140.95 per share.

What is the 52-week range for Cochlear?

Over the past 52 weeks, Cochlear has traded between A$88.74 and A$296.50.

How much debt does Cochlear have?

As of the most recent reporting period, Cochlear reported total debt of A$212.70M.

How much cash does Cochlear have on hand?

Cochlear reported A$187.70M in cash and cash equivalents in its most recent financial results.

What is Cochlear’s dividend yield?

Cochlear currently has a dividend yield of 3.21%.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.